Literature DB >> 8019751

Differential regulation of inositol 1,4,5-trisphosphate by co-existing P2Y-purinoceptors and nucleotide receptors on bovine aortic endothelial cells.

J R Purkiss1, G F Wilkinson, M R Boarder.   

Abstract

1. We have examined the inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) responses in bovine aortic endothelial (BAE) cells to purines (ATP, ADP and analogues) and the pyrimidine, uridine triphosphate (UTP). 2. Exchange of medium on BAE cells in the absence of agonist was found to be a stimulus for Ins(1,4,5)P3 generation. BAE cells stimulated with 100 microM ATP, 30 microM 2MeSATP (an agonist at P2Y-purinoceptors but not nucleotide receptors) or 100 microM UTP (an agonist at nucleotide receptors but not P2Y-purinoceptors) gave Ins(1,4,5)P3 responses above that caused by exchange of medium. The time course was rapid, with peak response within the first 5 s and levels returning close to basal after 30 s of stimulation. 3. Significant differences in Ins(1,4,5)P3 responses to 100 microM UTP and 30 microM 2MeSATP stimulation were observed. The response to UTP was reproducibly more sustained than that to 2MeSATP. 4. Stimulation of BAE cells with 100 microM UTP plus 30 microM 2MeSATP produced a response statistically indistinguishable from that predicted by addition of the responses to the two agonists in isolation. 5. The Ins(1,4,5)P3 response to UTP was attenuated to 25% of control by pretreatment of BAE cells with pertussis toxin. Responses to 2MeSATP and ADP were essentially unaffected. ATP stimulation was reduced to 65% of control. 6. Activation of protein kinase C with tetradecanoyl phorbol acetate (TPA) profoundly inhibited Ins(1,4,5)P3 responses to 2MeSATP and ADP but had no effect on UTP stimulation. The protein kinase C inhibitor, Ro 31-8220, enhanced responses to 2MeSATP, ADP and ATP but no effect was observed on UTP stimulation. 7. These observations show that nucleotide and P2Y-receptors mobilise the second messenger Ins(1,4,5)P3 by separate routes resulting in different patterns of generation and suggest that while ATP activates both receptors, ADP principally influences these cells by interacting with the P2Y-purinoceptors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8019751      PMCID: PMC1910100          DOI: 10.1111/j.1476-5381.1994.tb14797.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

1.  Mass measurements of inositol(1,4,5)trisphosphate in rat cerebral cortex slices using a radioreceptor assay: effects of neurotransmitters and depolarization.

Authors:  R A Challiss; I H Batty; S R Nahorski
Journal:  Biochem Biophys Res Commun       Date:  1988-12-15       Impact factor: 3.575

Review 2.  Is there a basis for distinguishing two types of P2-purinoceptor?

Authors:  G Burnstock; C Kennedy
Journal:  Gen Pharmacol       Date:  1985

3.  Stimulation of prostacyclin release from aortic smooth muscle cells by purine and pyrimidine nucleotides.

Authors:  D Demolle; C Lagneau; J M Boeynaems
Journal:  Eur J Pharmacol       Date:  1988-10-18       Impact factor: 4.432

4.  Culture of arterial endothelial cells: characterization and growth of bovine aortic cells.

Authors:  F M Booyse; B J Sedlak; M E Rafelson
Journal:  Thromb Diath Haemorrh       Date:  1975-12-15

5.  Specificity of P2-purinoceptor that mediates endothelium-dependent relaxation of the pig aorta.

Authors:  W Martin; N J Cusack; J S Carleton; J L Gordon
Journal:  Eur J Pharmacol       Date:  1985-02-05       Impact factor: 4.432

6.  Evidence for a nucleotide receptor on adrenal medullary endothelial cells linked to phospholipase C and phospholipase D.

Authors:  J R Purkiss; G F Wilkinson; M R Boarder
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

7.  The regulation of aortic endothelial cells by purines and pyrimidines involves co-existing P2y-purinoceptors and nucleotide receptors linked to phospholipase C.

Authors:  G F Wilkinson; J R Purkiss; M R Boarder
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

8.  Involvement of inositol 1,4,5-trisphosphate and calcium in the action of adenine nucleotides on aortic endothelial cells.

Authors:  S Pirotton; E Raspe; D Demolle; C Erneux; J M Boeynaems
Journal:  J Biol Chem       Date:  1987-12-25       Impact factor: 5.157

9.  Long-term phorbol ester treatment down-regulates protein kinase C and sensitizes the phosphoinositide signaling pathway to hormone and growth factor stimulation. Evidence for a role of protein kinase C in agonist-induced desensitization.

Authors:  J R Hepler; H S Earp; T K Harden
Journal:  J Biol Chem       Date:  1988-06-05       Impact factor: 5.157

10.  Different P2-purinergic receptor subtypes of endothelium and smooth muscle in canine blood vessels.

Authors:  D A Houston; G Burnstock; P M Vanhoutte
Journal:  J Pharmacol Exp Ther       Date:  1987-05       Impact factor: 4.030

View more
  13 in total

1.  Oscillations in cytosolic free Ca2+ induced by ADP and ATP in single rat hepatocytes display differential sensitivity to application of phorbol ester.

Authors:  C J Dixon; P H Cobbold; A K Green
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

2.  Capacitative Ca(2+) entry in vascular endothelial cells is mediated via pathways sensitive to 2 aminoethoxydiphenyl borate and xestospongin C.

Authors:  Nour B Bishara; Timothy V Murphy; Michael A Hill
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

3.  P2Y receptor-mediated Ca2+ signalling in cultured rat aortic smooth muscle cells.

Authors:  J D Pediani; J C McGrath; S M Wilson
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

4.  Differential regulation of P2Y(11) receptor-mediated signalling to phospholipase C and adenylyl cyclase by protein kinase C in HL-60 promyelocytes.

Authors:  B C Suh; T D Kim; I S Lee; K T Kim
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

5.  PKCbetaI mediates the inhibition of P2Y receptor-induced inositol phosphate formation in endothelial cells.

Authors:  B C Chen; W W Lin
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

6.  PPADS: an antagonist at endothelial P2Y-purinoceptors but not P2U-purinoceptors.

Authors:  C Brown; B Tanna; M R Boarder
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

7.  Evidence for requirement of tyrosine phosphorylation in endothelial P2Y- and P2U- purinoceptor stimulation of prostacyclin release.

Authors:  A Bowden; V Patel; C Brown; M R Boarder
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

8.  Pharmacological selectivity of the cloned human P2U-purinoceptor: potent activation by diadenosine tetraphosphate.

Authors:  E R Lazarowski; W C Watt; M J Stutts; R C Boucher; T K Harden
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

9.  Evidence for Purinergic Receptors in Vestibular Dark Cell and Strial Marginal Cell Epithelia of Gerbil.

Authors:  Jianzhong Liu; Kenichi Kozakura; Daniel C Marcus
Journal:  Audit Neurosci       Date:  1995

10.  Protein kinase C isoforms in bovine aortic endothelial cells: role in regulation of P2Y- and P2U-purinoceptor-stimulated prostacyclin release.

Authors:  V Patel; C Brown; M R Boarder
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.